These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9824779)

  • 1. Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients.
    Marshall JD; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1998 Nov; 38(11):994-1002. PubMed ID: 9824779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):414-23. PubMed ID: 8873689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):405-13. PubMed ID: 8873688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):424-34. PubMed ID: 8873690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide.
    Ryoo SH; Lee MG; Lee MH
    Biopharm Drug Dispos; 1993 Apr; 14(3):245-55. PubMed ID: 8490111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new "loop" diuretic.
    Flamenbaum W; Friedman R
    Pharmacotherapy; 1982; 2(4):213-22. PubMed ID: 6763204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly.
    Oberbauer R; Krivanek P; Turnheim K
    Clin Pharmacol Ther; 1995 Jan; 57(1):42-51. PubMed ID: 7828380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bumetanide continuous infusions in critically ill pediatric patients.
    McCallister KM; Chhim RF; Briceno-Medina M; Shelton CM; Figueroa M; Rayburn M
    Pediatr Crit Care Med; 2015 Feb; 16(2):e19-22. PubMed ID: 25560424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.
    Pacifici GM
    Paediatr Drugs; 2012 Aug; 14(4):233-46. PubMed ID: 22702741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous bumetanide.
    Yoon WH; Lee SH; Lee MG
    J Pharm Sci; 1995 Feb; 84(2):236-42. PubMed ID: 7738809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.
    Koff RS
    J Clin Pharmacol; 1981; 21(11):706-11. PubMed ID: 7040497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate.
    Donovan MD; Abduljalil K; Cryan JF; Boylan GB; Griffin BT
    Biopharm Drug Dispos; 2018 Mar; 39(3):125-134. PubMed ID: 29319897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide, a new diuretic.
    Hofstetter A
    Int Urol Nephrol; 1974; 6(1):35-42. PubMed ID: 4617729
    [No Abstract]   [Full Text] [Related]  

  • 16. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH; Wennevold A
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bumetanide treatment of renal edema. Comparison with furosemide.
    Whelton A
    J Clin Pharmacol; 1981; 21(11):591-8. PubMed ID: 7040493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease.
    Moffett BS; Moffett TI; Dickerson HA
    Am J Ther; 2007; 14(4):331-5. PubMed ID: 17667206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of bumetanide in the newborn infant.
    Lopez-Samblas AM; Adams JA; Goldberg RN; Modi MW
    Biol Neonate; 1997; 72(5):265-72. PubMed ID: 9395836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations.
    Hamed E; Gerson MC; Millard RW; Sakr A
    Int J Pharm; 2003 Nov; 267(1-2):129-40. PubMed ID: 14602391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.